-
P695457-10mg(±)-2-Propyl-4-pentenoic acid has a wide range of applications in life science related research.
-
P695457-100mg(±)-2-Propyl-4-pentenoic acid has a wide range of applications in life science related research.
-
P690734-1g
Aladdin
1-(4-(methylthio)phenyl)hydrazine hydrochloride (C09-1612-809)
Price: $539.87List Price: $599.861-(4-(methylthio)phenyl)hydrazine hydrochloride. -
P690734-100mg
Aladdin
1-(4-(methylthio)phenyl)hydrazine hydrochloride (C09-1612-808)
Price: $81.65List Price: $90.731-(4-(methylthio)phenyl)hydrazine hydrochloride. -
P664514-5mgParis saponin V, a natural product from Veratrum, induces apoptosis in human cancer cells in vitro via inhibition of the STAT3 signaling pathway and glycolysis.
-
P664514-50mgParis saponin V, a natural product from Veratrum, induces apoptosis in human cancer cells in vitro via inhibition of the STAT3 signaling pathway and glycolysis.
-
P664514-25mgParis saponin V, a natural product from Veratrum, induces apoptosis in human cancer cells in vitro via inhibition of the STAT3 signaling pathway and glycolysis.
-
P664514-1mgParis saponin V, a natural product from Veratrum, induces apoptosis in human cancer cells in vitro via inhibition of the STAT3 signaling pathway and glycolysis.
-
P651581-50mgPlecanatide, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. Plecanatide activates GC-C receptors to stimulate cGMP synthesis with an EC 50 of 190 nM in T84 cells assay. Plecanatide shows
-
P651581-25mgPlecanatide, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. Plecanatide activates GC-C receptors to stimulate cGMP synthesis with an EC 50 of 190 nM in T84 cells assay. Plecanatide shows
-
P651581-1mgPlecanatide, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. Plecanatide activates GC-C receptors to stimulate cGMP synthesis with an EC 50 of 190 nM in T84 cells assay. Plecanatide shows
-
P649469-5mgPonatinib (AP24534) hydrochloride is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC 50 s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl , PDGFRα , VEGFR2 , FGFR1 , and Src ,